Alignment Healthcare, Inc.
ALHC
$15.80
$0.785.19%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 49.27% | 47.70% | 50.71% | 52.03% | 47.54% |
| Total Other Revenue | 26.32% | 26.17% | 48.26% | 22.60% | 30.72% |
| Total Revenue | 49.03% | 47.46% | 50.68% | 51.61% | 47.34% |
| Cost of Revenue | 45.67% | 43.21% | 47.19% | 54.18% | 47.41% |
| Gross Profit | 75.78% | 91.45% | 81.30% | 34.27% | 46.85% |
| SG&A Expenses | 18.04% | 14.56% | 17.67% | 11.43% | 24.59% |
| Depreciation & Amortization | 7.85% | 16.45% | 6.22% | 38.98% | 24.99% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 41.86% | 39.11% | 41.75% | 46.85% | 43.87% |
| Operating Income | 229.60% | 89.57% | 52.94% | 31.43% | 24.00% |
| Income Before Tax | 178.72% | 79.96% | 34.28% | 24.63% | 15.84% |
| Income Tax Expenses | 14,554.55% | -- | 129.17% | -- | 2,100.00% |
| Earnings from Continuing Operations | 165.21% | 79.92% | 34.23% | 24.65% | 15.76% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 300.00% | 344.44% | -222.73% | -46.67% | -141.18% |
| Net Income | 165.25% | 80.41% | 34.14% | 24.64% | 15.69% |
| EBIT | 229.60% | 89.57% | 52.94% | 31.43% | 24.00% |
| EBITDA | 365.15% | 107.89% | 63.60% | 48.84% | 37.80% |
| EPS Basic | 162.80% | 80.86% | 35.38% | 26.24% | 17.83% |
| Normalized Basic EPS | 179.40% | 83.44% | 47.73% | 23.19% | 20.08% |
| EPS Diluted | 153.85% | 80.86% | 35.38% | 26.24% | 15.09% |
| Normalized Diluted EPS | 175.13% | 83.44% | 47.73% | 23.19% | 20.08% |
| Average Basic Shares Outstanding | 3.90% | 2.43% | 1.89% | 2.15% | 2.63% |
| Average Diluted Shares Outstanding | 9.76% | 2.43% | 1.89% | 2.15% | 2.63% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |